Eli Lilly and Company
GIP/GLP1 agonist compositions
Last updated:
Abstract:
A composition of tirzepatide, comprising an agent selected from NaCl and propylene glycol; and dibasic sodium phosphate is provided.
Status:
Grant
Type:
Utility
Filling date:
14 Jun 2019
Issue date:
14 Jun 2022